You are here

  • Home
  • Archive
  • Volume 11, Issue 10
  • SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models

Article metrics

Article menu
Basic tumor immunology
Original research
SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models

 

Online download statistics by month:

Online download statistics by month: October 2023 to November 2025

AbstractFullPdf
Oct 202311401144442
Nov 2023729731188
Dec 2023512515170
Jan 2024269270142
Feb 2024288288153
Mar 2024534536217
Apr 2024518522182
May 2024365375159
Jun 2024397398139
Jul 2024540545169
Aug 2024381379313
Sep 2024449450223
Oct 2024491500280
Nov 2024547554247
Dec 2024453458199
Jan 2025475478207
Feb 2025654656238
Mar 2025417419151
Apr 2025343343103
May 2025389390146
Jun 202525725878
Jul 2025112
Nov 2025110
Total10150102114148